The global controlled release drug delivery market size accounted for USD 61.14 billion in 2024, grew to USD 66.80 billion in 2025 and is projected to surpass around USD 148.24 billion by 2034, representing a healthy CAGR of 9.26% between 2024 and 2034. The North America controlled release drug delivery market size is calculated at USD 26.29 billion in 2024 and is expected to grow at a fastest CAGR of 9.38% during the forecast year.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Controlled Release Drug Delivery Market
5.1. COVID-19 Landscape: Controlled Release Drug Delivery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Controlled Release Drug Delivery Market, By Technology
8.1. Controlled Release Drug Delivery Market, by Technology, 2024-2034
8.1.1 Coacervation
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Wurster Technique
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Implants
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Micro Encapsulation
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Targeted Delivery
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Transdermal
8.1.6.1. Market Revenue and Forecast (2021-2034)
8.1.7. Others (Liposomes, Microelectromechanical Technology)
8.1.7.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Controlled Release Drug Delivery Market, By Release Mechanism
9.1. Controlled Release Drug Delivery Market, by Release Mechanism, 2024-2034
9.1.1. Partition Controlled Micro Reservoir Drug Delivery Systems
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Polymer Based Systems
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Drug Delivery Systems, which are Feedback Regulated
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Drug Delivery Systems that are Activation-modulated
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Chemically Activated
9.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Controlled Release Drug Delivery Market, By Application
10.1. Controlled Release Drug Delivery Market, by Application, 2024-2034
10.1.1. Injectable
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Metered Dose Inhalers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Infusion Pumps
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Ocular and Transdermal Patches
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Oral Controlled-drug Delivery Systems
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Eluting Drug Stents
10.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Controlled Release Drug Delivery Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Technology (2021-2034)
11.1.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.1.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Technology (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Technology (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Technology (2021-2034)
11.2.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.2.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Technology (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Technology (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Technology (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Technology (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Technology (2021-2034)
11.3.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.3.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Technology (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Technology (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Technology (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Technology (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Technology (2021-2034)
11.4.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Technology (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Technology (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Technology (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Application (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Technology (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Application (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Technology (2021-2034)
11.5.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.5.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Technology (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Application (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Technology (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Release Mechanism (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Application (2021-2034)
Chapter 12. Company Profiles
12.1. Merck and Co., Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Orbis Biosciences, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Johnson and Johnson
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Alkermes plc
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Corium International, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Coating Place, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Pfizer, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Depomed, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Capsugel
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Aradigm Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample